Summary of Purpose
The Alpha-Tocopherol Beta-Carotene Cancer Prevention (ATBC) Study was a large randomized, double-blind, placebo-controlled, 2x2 factorial design, primary prevention trial testing the effects of alpha-tocopherol and beta-carotene supplements on cancer incidence and mortality conducted in Finland as a collaboration between the Public Health Institute (KTL) of Finland and the U.S. National Cancer Institute. The...Read More →
The following dates are available for this trial. Trial information last updated on 2 May 2018.
|31 Aug 1985||19 Jun 2006||Unavailable||Unavailable||19 Mar 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Conditions See All
- Perspective: Prospective